Hacker News new | past | comments | ask | show | jobs | submit login

I guess that raises a few questions.

1) How do they keep them high? They are buying these services from a third-party.

2) These cost of clinical trials is increasing because FDA evidence requirements are getting stricter and stricter. Back in the 1950s, you could get a drug approved in under 2 years. Now? It's more like 5-8 years. Of course, you end up with much safer drugs this way.




I think #2 answers #1. AKA, they have pushed legislation to increase FDA requirements.


Actually this a well known process known as regulatory capture.

Where the regulated industry ends up in some kind of symbiosis with its regulator, encouraging it to both grow and to keep competition at bay.

The conflict between the regulators and the regulated industry is largely a farce as they know they need each other.


Considering drug companies are always fighting with the FDA to do the bare minimum in terms of clinical studies, I would fathom to guess that your theory can't be supported with the existing evidence.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: